We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOMO
1351
Hello Group
MOMO
$869M
$2.32M ﹤0.01%
255,400
+168,916
+195% +$1.61M
DOO
1352
Bombardier Recreational Products
DOO
$4.58B
$2.31M ﹤0.01%
+29,583
New +$2.44M
PEPLW
1353
CALL
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$2.3M ﹤0.01%
223,272
IYK icon
1354
iShares US Consumer Staples ETF
IYK
$1.44B
$2.3M ﹤0.01%
+34,596
New +$2.26M
MDAIW icon
1355
CALL
Spectral AI Warrants
MDAIW
$5.67M
$2.3M ﹤0.01%
221,988
-163,012
-42% -$12.4K
EWC icon
1356
iShares MSCI Canada ETF
EWC
$6.18B
$2.29M ﹤0.01%
67,100
-65,000
-49% -$2.23M
FMIVW
1357
CALL
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$2.29M ﹤0.01%
224,995
FDS icon
1358
Factset
FDS
$10.1B
$2.28M ﹤0.01%
5,489
-14,399
-72% -$6M
USB icon
1359
PUT
US Bancorp
USB
$100B
$2.28M ﹤0.01%
63,200
-22,000
-26% -$980K
DFS
1360
DELISTED
Discover Financial Services
DFS
$2.27M ﹤0.01%
+23,004
New +$2.46M
APMI
1361
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$2.27M ﹤0.01%
218,585
OPA.WS
1362
CALL
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$2.27M ﹤0.01%
219,314
AVACW
1363
CALL
DELISTED
Avalon Acquisition Inc. Warrant
AVACW
$2.25M ﹤0.01%
215,853
SKYW icon
1364
Skywest
SKYW
$4.51B
$2.25M ﹤0.01%
+101,542
New +$1.99M
FITB
1365
CALL
Fifth Third Bancorp
FITB
$52.4B
$2.25M ﹤0.01%
+84,500
New +$2.81M
DBD
1366
DELISTED
Diebold Nixdorf Incorporated
DBD
$2.25M ﹤0.01%
+1,873,310
New +$4.17M
DAO
1367
Youdao
DAO
$1.93B
$2.24M ﹤0.01%
263,659
+220,895
+517% +$1.75M
CCV.WS
1368
CALL
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$2.24M ﹤0.01%
221,957
PBR icon
1369
Petrobras
PBR
$116B
$2.23M ﹤0.01%
214,104
-2,675,498
-93% -$29.1M
OM icon
1370
Outset Medical
OM
$87.5M
$2.23M ﹤0.01%
+8,090
New +$2.97M
GOSS icon
1371
Gossamer Bio
GOSS
$100M
$2.23M ﹤0.01%
1,770,413
+754,963
+74% +$1.45M
MBC icon
1372
MasterBrand
MBC
$1.15B
$2.23M ﹤0.01%
277,214
+49,143
+22% +$433K
MS icon
1373
PUT
Morgan Stanley
MS
$333B
$2.22M ﹤0.01%
+25,300
New +$2.36M
PVLA
1374
Palvella Therapeutics
PVLA
$2.05B
$2.22M ﹤0.01%
28,329
-1,571
-5% -$182K
PCAR icon
1375
PACCAR
PCAR
$72.7B
$2.22M ﹤0.01%
30,293
-11,665
-28% -$835K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.